Bordeaux, Boston, June 2, 2016 – IMPLANET (Euronext: IMPL, FR0010458729, PEA-PME eligible; OTCQX: IMPZY), a medical technology company specializing in vertebral and knee-surgery implants, announces today the decision of the Board of Directors to nominate Mary E. Shaughnessy as a new Board Director.
Drawing on 20 years of experience working for Partners Healthcare System in Boston, Mary brings a wealth of specific expertise in the healthcare finance and reimbursement sector. In her capacity as the Senior Vice President of Finance, Partners Continuing Care (PCC), Mary has played an integral role in the strategic planning process, reviewed monthly financial results to maximize revenue, improved payment rates from commercial and government payers and implemented a payer / service line profitability analysis for respective hospitals within Partners.
Mary E. Shaughnessy says: “I am excited about the opportunity, impressed by the management team and I look forward to working with a solutions oriented company with novel technology that can make a real difference in patients’ lives. The technology that Implanet is developing will also provide physicians with important tools in a fast moving healthcare environment.”
Ludovic Lastennet, CEO, concludes, “We are proud to welcome Mary E. Shaughnessy as an independent Board Director. Her vast experience in hospital administration and reimbursement strategies will prove invaluable as Implanet expands the JAZZ technology platform in a reimbursement environment that compels medical device suppliers to provide demonstrable value added benefits as an essential complement to documented clinical efficacy.”
Contacts
Florent ALBA
NewCap
Investor Relations | Strategic Communication
21 Place de la Madeleine – 75008 Paris – France
Tel: +33 1 44 71 98 55
